The Obesity Medicine Association will host its annual conference in San Deigo from April 10-12, diving into the latest ...

The Endocrine Society has concerns of possible delays in care and other problematic areas of The Lancet Commission’s proposed new obesity framework; a Commission author cites ‘conceptual confusions.’ ...

The Lancet obesity framework aims to improve risk assessment but risks delaying treatment and deepening health inequities, according to recent evaluations.

As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis. Megan Tatum reports.

Routine assessment of organ dysfunction or functional limitations also exceeds the capacity of most primary care settings, ...

The American Heart Association released updated dietary guidance suggesting that following 9 key steps may significantly ...

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health ...

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health ...

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health problems may complicate diagnosis and delay treatment, according to an Endocrine ...

Medications like GLP-1 agonists, as well as minimally invasive bariatric surgeries, offer lasting results with few complications. At the same time, healthy eating and regular physical activity remain ...

The FDA approved a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight with weight-related ...

Learn how doctors categorize obesity into classes using BMI, as well as related health risks and treatments based on the ...